Stay updated on SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Sign up to get notified when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.

Latest updates to the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0. This appears to be a routine site version update with no changes to the study data or details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.4.3 is shown in the page's revision history, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The study content, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check109 days agoChange DetectedThe page now consolidates study locations under a single Locations section listing Florida, Illinois, Kentucky, and Virginia; separate location sections/pages for these states have been removed.SummaryDifference0.6%

Stay in the know with updates to SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.